Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Expands, Extends Johnson & Johnson Deal

Premium

PALO ALTO, Calif.--Incyte Pharmaceuticals this month expanded a genomic partnership with Johnson & Johnson that began in 1996. Johnson & Johnson will receive access to multiple Incyte databses in exchange for annual fees, future milestone payments, and royalties to Incyte on the sale of products developed with its technology and data.

Among the databases is Incyte's newest product, the LifeSeq Gold assembled database, an extensive source of human gene and expression information assembled from preexisting Incyte databases using new and proprietary bioinformatics algorithms. Incyte claimed LifeSeq Gold is the most complete set of genetic data available on the human genome.

The deal also gives Johnson & Johnson access to Incyte's LifeSeq Atlas mapping and ZooSeq animal gene sequence and expression databases, as well as continued access to the PathoSeq microbial database.

Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.